Introduction
The high heterogeneity in malignancies of leukaemias leads to an extensive routine diagnostic workup which now includes immunophenotyping, cytogenetic and molecular genetic studies in addition to the classical morphology and cytochemistry-based diagnosic tests.
have shown immmunophenotypic features of precursor B-and T-cell ALL differ remarkably. Asynchronous or aberrant combinations of B-and T-associated antigens which do not reflect normal lymphoid ontogeny have been demonstrated in the vast majority of precursor B-and T-cell ALL cases. 1 Even with standard techniques, in 5-10% of cases making a diagnosis is complicated. The diagnosis of lymphoid malignancies may be supported by clonality assessment based on identically (clonally) rearranged T-cell receptor (TCR) genes. TCR gene rearrangements are also important markers suitable for the detection of minimal residual disease. 7 Furthermore, chromosomal translocations in the pathogenesis of T-ALL, involves many genes that are activated due to the disturbances in the rearrangement process of the TCR genes. 8 The TCR-gamma gene rearrangements have long been used for detection of lymphoid clonality and represent a model of restricted repertoire targets. It is a preferential target for clonality analyses since it is rearranged at an early stage of T lymphoid development in both TCR-alpha beta and TCR-gamma delta lineage precursors and unlike TCR-delta remains undeleted in TCR-alpha beta lineage cells. 7 The treatment outcome of acute leukaemias has improved markedly in recent years, although certain areas remain unresolved. CR rates of more than 80% and a leukemia-free survival above 50% can be achieved in T-ALL. The use of prognostic factors in risk stratification has aided in selection of the best treatment regime.
Within T-ALL, subtype was the most significant prognostic factor. The leukemia-free survival was significantly poorer for early T-ALL (25%) and mature T-ALL (28%) compared to thymic T-ALL (63%). 3 Immunophenotypic features associated with an increased risk of failure also included membrane expression of CD3 or MHC class II antigen (HLA-DR) and negativity of CD2, CD5, THY antigen (similar to CD1) or CD10. 1 Our aim was to observe if the phenotype of T-cell leukaemia and lymphoma cases here could be grouped according to standard maturation stages and whether these stages were supported by a unique TCR-gamma gene rearrangement pattern. These stages may be useful in prognostication.
Methods and materials

Samples
Bone marrow or peripheral blood aspirates were collected from adult and paediatric patients warded in University Hospital, Kuala Lumpur (now known as University Malaya Medical Centre) or from samples sent to UHKL between September 1988 and September 1990. These were new or relapsed cases of ALL, AML or patients with non-Hodgkin's lymphoma (NHL) suspected of marrow infiltration. All procedures complied with the policy statement in the Declaration of Helsinki (2008). Verbal consents were obtained.
Inclusion criteria: Cases with high expression (.20%) of CD7 or CD2 and negative expression (,20%) of non-T lineage markers (CD19, CD10, CD13 and CD33). Exclusion criteria: Cases with incomplete analysis for the panel of T-lineage markers (CD7, CD2, CD5, CD1, CD4, CD8, CD3 and TCR-alpha beta).
Immunocytochemistry
Mononuclear cell (MNC) isolation
MNC was isolated by density gradient centrifugation using Ficoll-pague (Pharmacia Molecular Biologicals, Sweden) and washed with Phosphate Buffered Saline Dulbecco 'A' (PBSa, Oxoid Limited, England). Cell viability of fresh or frozen samples was determined to be above 70%.
Monoclonal antibodies (Moab)
Negative control (non-immune immunoglobulin of all subtypes, Mouse IgG 1, 2a, 2b, 3), HLA-DR, B4 (CD19), T2 (CD7), T3 (CD3), T4 (CD4), T6 (CD1a), T8 (CD8) and normal rabbit serum were obtained from Dakopatt, Denmark. CALLA (CD10), T1 (CD5), T11 (CD2) and TCR-1 (WT-31) were purchased from Becton Dickinson (Franklin Lakes, NJ, USA). My7 (CD13) and My9 (CD33) were purchased from Coulter Corporation (Miami, FL, USA). The antibodies were reconstituted as recommended.
Monoclonal antibody labelling
Standard protocols for antibody labelling were followed. Cells were initially resuspended in 10-20% of heat inactivated, normal rabbit serum in PBSa (PBS without calcium and magnesium). One million cells were incubated with antibodies in separate tubes. After 30 minutes incubation on ice (4uC), a cell pellet was obtained and pipetted onto an ethanol cleaned microscope slide. Slides were then left to dry overnight.
Peroxidase staining
Staining was performed using the Immunoperoxidase staining kit (Cambridge Research Laboratory, Cambridge, MA, USA) according to protocol provided by manufacturer.
Southern blot
T-cell receptor-gamma probe
The human gamma cDNA probe was the kind gift of Dr Tak W. Mak from the Medical Biophysics Department of the University of Toronto. The HGP 02 clone isolated from peripheral blood contained VJCc1 sequences of the TCR-gamma gene. 9 Clones were grown on LB agar. Plasmid was isolated using the alkaline lysis method described in the literature 10 and concentrated using the CsCl-dye bouyant density gradient. Plasmid was digested with EcoRI to release the cDNA insert. Insert was separated on an agarose gel. The insert identified by the expected DNA band size was eluted out, purified with phenol-chisam and precipitated in 3M sodium acetate (pH 5 . 2) and 70% ethanol. Dried DNA was dissolved in sterile distilled water.
DNA extraction
Cell nuclei were extracted using 26 sucrose-triton and digested overnight with proteinase K (5 mg/ml). DNA was extracted with Tris saturated phenol (Tris-HCL, pH 8 . 0) and chisam and precipitated with 7 . 5M ammonium acetate and 95% ethanol. Dried DNA was dissolved in TE buffer.
Restriction enzyme digestion
DNA (10 mg) was digested overnight at 37uC with 50 units of EcoRI, BamHI and HindIII, respectively.
Gel electrophoresis and DNA transfer
Digested DNA was separated at 20 V, overnight on a 0 . 8% agarose gel prepared in 0 . 56 TBE. A manual method was used to transfer denatured DNA to nylon membranes as described in the literature.
10
Labelling of cDNA A 0 . 5-1 . 0 mg of the DNA probe was random primed with radiolabelled dCTP using Klenow according to the method of Feinberg and Vogelstein.
11,12
Hybridization A pre-hybridization with 56 Denhardt's reagent was followed by a second pre-hybridization step with 200 mg/ml denatured salmon sperm DNA. Hybridization was carried out in denatured salmon sperm DNA (50 mg/ml) and denatured radiolabelled probe 65uC for 16-48 hours. Two different posthybridization washes were carried at 50uC. Nylon filters wrapped in cling film were exposed to films in X-ray cassettes for 1-8 days at 270uC.
Results
A total of 33 T-lineage leukaemia/lymphoma cases were included in this study. Two cases of B-lineage and four cases of myeloid-lineage leukaemias were added as control. Table 1 shows the demographic distribution of patients, total white blood count, per cent blast in peripheral blood, cytochemistry test results and preliminary diagnosis made by the haematologists. The majority were adults (.15 years) (78%) and male (88%). Table 2 shows the immunophenotyping results of the leukaemia samples. The normal control was collected from the Blood Bank, UHKL. The immunologic subtypes were staged as Pro-T (CD7z) (T-I), Pre-T (CD7zCD2z, and/or CD5z and/or CD8z) (T-II), Cortical-T (CD7z, CD2z, CD1az) (T-III), Mature-T (CD7z, CD2z, membrane CD3z, CD1a-, TCRalpha betaz or TCR-gamma deltaz) (T-IV). In the Pre-T category which is also defined by the mandatory negative expression of CD1, 13 there was evidence of CD4 and/or CD8 expression among the cases here. A subcategory of Pro-T (Ia) and Pre-T (IIa) stage were differentiated by the lack of HLA-DR expression. Controls expressed high levels of B-lineage (CD19 and or CD10) and myeloid-lineage (CD13 and or CD33) markers, respectively and lacked CD7 expression. Gene rearrangement patterns of the TCR gamma gene in EcoRI, BamHI and HindIII digested DNA were determined from respective published studies on acute leukaemia. 9,14-22 A V to J rearrangement is generally followed by a VJ to C resulting in a unique VJC recombination. Rearrangement into Cc1 usually precedes Cc2 and rearrangement into Cc2 results in deletion of Cc1 as seen in studies on acute leukaemia. 19, 20 This suggests rearrangement into Cc1 is an earlier event in cell maturation.
In EcoRI digested DNA a heterozygous rearrangements of alleles may result in G/C1 and C1/C2 patterns. We found in several samples (T-18, T-23, T-24 and T-29), a C1/C2 pattern was observed even though hybridization with other restriction enzyme digestions showed C2/C2 patterns. This may be due to Vc rearrangements which involved segments 59 to Vc9 (VcII) i.e. VcIII and VcIV, 7 leaving the 5 . 2 kb band intact or rearrangements which resulted in a similar band size. These patterns were re-written as C2/C2zV9/R5. Table 3 shows gene rearrangement status of the TCR-gamma gene in leukaemia samples. Figure 1 shows gene rearrangement patterns of the TCR gamma gene in EcoRI, BamHI and HindIII digested DNA of T-cell representative samples.
Discussion
The cases included in this study were T-cell acute leukaemia or NHL cases collected over a two year period. The diagnosis made by haematologists at that time was without the benefit of immunophenotyping results, which was conducted only for research. Thus, less than 17% of these cases were identified as Tlineage.
The incidence (per 100 000) of lymphatic leukaemia in Malaysia was 4 . 5 in 2003. The male/female ratio was 1 . 7 : 1 and there were 2 . 4 times more paediatric than adult cases. 23 About 22% of these patients were identified as T-lineage. 24 In this study, the male/female ratio was higher (5 . 6 : 1) and there were more adult patients (2 : 1). The higher number of adult cases may be due to the inclusion of NHL cases, which was reported to be 11 : 1. 23 Nevertheless, this did not explain the increased ratio of male cases, which was reported similar to lymphatic leukaemia (1 . 6 : 1). T-lineage NHL makes up 17% 25 to 39% 26 of these cases. A mediastinal mass was observed in 15% of patients here. Mediastinal tumor is found in both ALL and NHL. 27 In adults, the reported incidence is 44% 28 and 61% was observed in paediatric T-cell ALL. 29 The presence of a mediastinal mass has not been shown to affect treatment outcome. 29 However, a recent study with newer treatment regimen implied that the probability of a 5-year event free survival may be higher in T-ALL paediatric patients with a mediastinal mass. 30 A significantly shorter median survival was reported in HLA-DRz subgroup. 31 We observed HLA-DRz cases (in Pre-T stage patients) were absent for a mediastinal mass while the opposite was true for the HLA-DR-cases. If the study by Attarbaschi et al. 30 is found true, these two indicators may be useful as prognostication markers at least in Pre-T stage patients. Studies suggest an arrest of adult T ALL at a less mature differentiation stage (Pro-/Pre-T) than in childhood, which may be closely related to the worse outcome observed in these patients. 32 We observed a high ratio of adult/children (9 : 1) in Pro-T cases. The majority (41%) of adult cases were in this subgroup. The majority (45%) of childhood cases were in the Pre-T subgroup followed by Cortical-T stage (27%).
Immunoenzyme methods such as immunoperoxidase assay have the advantage of not requiring access to expensive equipments such as fluorescent activated cell sorter or a fluorescent microscope.
Thus, it is most suitable for small clinical laboratories. Nevertheless, immunophenotyping of all leukaemia cases in Malaysia is now performed using flowcytometry.
The use of a standardized panel of monoclonal antibodies to B and T cells, and myeloid cells permits allocation of more than 98% of acute leukemia to their respective lineage. However, confusion exists in the definition of acute unclassifiable and acute undifferentiated leukemia (AUL) which are believed to be very early cells. The use of cytoplasmic antigens has been proposed since antigens first appear in the cytoplasm during early differentiation and are only expressed on the membrane later. 33 Our panel of Tcell markers did not include cytoplasmic CD3 (cCD3) T-2  1  0  2  5  40  84  5  5  0  2  3  5  ND  Ia  T-3  1  0  0  0  43  92  5  0  0  1  0  5  4  Ia  T-4  2  7  12  9  42  72  10  8  4 T-10 20  2  0  0  0  92  10  2  0  0  5  3  2  Ib  T-11 8  0  ND  ND  27  31 wk 28 wk 21  4  24  16  12  15  IIa  T-12 14  0  1  23  69  71  42 wk 15  4  4  6  9  ND  IIa  T-13 4  0  4  0  94  79  21  73 wk 0  1  5  0  7  IIa  T-14 0  0  1  0  80  62  61  0  0  3  4  9  6  IIa  T-15 5  0  ND  ND  30  54  58  1  1  11  12  7  0  IIa  T-16 0  0  ND  ND  0  70  88  25 wk 9  2  86  2  0  IIb  T-17 0  0  0  0  2  9 wk  55  0  3  39  31  1  0  IIb  T-18 1  ND  ND  ND  3  94  10 wk 5  0  25  15  2  2  IIb  T-19 7  0  ND  ND  0  74  90  37  0  26  36  5  1  IIb  T-20 0  0  0  0  0  96  78  3  15  53  2  3  1  III  T-21 0  0  ND  0  2  88  79  35 wk 36  0  0  0  0  III  T-22 2  15  11  11  7  28 wk 78  30  34  12  21  19  ND  III  T-23 0  0  0  0  0  40 wk 90  0  76  56  84  7  4  III  T-24 1  ND  1  0  0  89  88  46  26  43  11  21  9  III  T-25 1  0  ND  ND  1  74  21 wk 60  16  60  28  3  4  III  T-26 0  0  0  0  5  80  94  12  20  85  86  7  3  III  T-27 3  15  3  3  3  84  96  73  60  86  89  24  18  III  T-28 5  0  5  0  2  86  96  66  24  94  95  28  23  III  T-29 0  0  0  0  0  91  95  85  25  84  73  22  94  III  T-30 0  0  ND  ND  11  84  21 wk 51 wk 0  2  2  80  1  VI  T-31 6  0  0  2  0  50  61  35  0  30  46  58  41  VI  T-32 0  0  0  0  27  16  55  13  0  86  1  40  11 wk VI  T-33 0  0  36  31  40  21  42  26  13  47  8  49  42  VI  C-32 86  94  0  0  81  3  -------C-ALL  C-76 49  12  7  -74  15  -------SmIg536%  M-17 2  0  45  67  90  0  -------M1  M-18 1  0  0  95  0  0  -------M3  M-23 0  0  47  79  60  0  -------M1  M-43 7  0  51  34  56  0  ------ since this work was performed prior to the EGIL recommendation. AUL cases are negative for cCD3 but two-third were observed to express surface CD7. Other surface markers expressed were HLA-DR and CD34. 34 The lack of cCD3 in our study may have resulted in the inclusion of AUL cases into the Pro-T subgroup. The similar high expression of HLA-DR suggests an early subgroup with common ancestry with HLA-DRz Pre-T cells. Even though cCD3 is highly specific for the identification of T-lineage cases, 35 the cell permeabilization process to detect cytoplasmic and nuclear antigens is painstaking. Furthermore, the complete panel of markers needed for the EGIL scoring system is too costly and labour intensive. A study carried out to determine how many and which markers should be included for the diagnosis of acute leukemias showed a combination of four flow cytometic markers, CD2, CD3, CD5, and CD7 detected on cell surface, was sufficient to achieve a target sensitivity of more than 95% for T-lymphoid malignancies. 36 Furthermore, AUL forms less than 1% of adult acute leukaemias. 34 We used CD7, CD2, CD1 and CD3 to place the cases here into the four EGIL stages. We were able to fit all cases except one (T-19) which was highly expressed for only CD7 and weakly expressed for CD2. However, the presence of CD4 and CD8 with no other mature markers led us to place it into Pre-T instead of the Pro-T subgroup. Analysis of TCRgamma showed rearrangement involving the second constant region confirming a more mature status.
In the interpretation of results obtained from peripheral blood samples, it was necessary to consider contribution from contaminating normal T cells. The exclusion of these cells was largely performed by excluding smaller cells of lymphocytes.
When CD4 and CD8 markers were then analyzed, we observed heterogeneous expression of these markers in the last three maturation stages consisting of double negative, single positive and double positive combinations. These are all possible expression 
G, germline; C1, rearrangement involving constant region 1; C2, rearrangement involving constant region 2; R, rearranged; V9, Vc9; D, deleted band.
patterns during T-cell maturation including a mature (CD3z) double negative sample (T-30) which was negative for TCR-alpha beta. 37 This may be cells expressing the TCR-gamma delta receptor. The cases in this cohort presented phenotypes that appeared to be normal cellular counterparts from the malignant proliferation of rare normal lymphoid cells than asynchronous or aberrant expression of antigens the options of which remains a controversy in the scientific community. 32 HLA-DR is associated with an early phenotype in T-lineage ALL. 31 Heterogeneous expression of HLA-DR of cases in both Pro-T and Pre-T stages were observed. When HLA-DRz and HLA-DR-subgroups were created within these stages and observed for TCR-gamma rearrangement, we found a less rearranged state in both the HLA-DRz subgroups. The possibility of a difference at the genetic level emphasizes the implication that these two groups of cells may have different origin. Prothymocytes Tp41z (CD7)/TdTz and T11z(CD2)/TdTz present in low frequencies in human normal bone marrow were also positive for HLA-DR. 38 A study of early thymocytes from human thymus however concluded that although expressed on a significant amount of thymocytes, the HLA-DR antigen showed no relation with the T-cell differentiation stages. 39 Therefore, it may be possible that HLA-DRz cases resulted from transformation of cells in the bone marrow while HLA-DR-cells originated from the thymus. This may also explain the higher incidence of mediastinal mass in HLA-DR-cases 31 as also indicated in our samples. The mature double negative sample, negative for TCR-alpha beta was similar in genotype to another report on TCR-gamma delta T-cell ALL which was rearranged into C1 on one allele and C2 on the other. 20 For one case of Sezary syndrome (SS) (T-33), immunophenotype confirmed a mature phenotype. Sezary cells in the blood typically show a CD4 positive and CD7 negative immunophenotype. TCRgamma 40 and TCR-beta 41 are usually rearranged in these samples. Our case however showed no rearrangement for all TCR genes (data not shown). The dissociation between genotype and phenotype where an immature genotype is associated with late activation markers may be possible in cells transformed by viruses. 42 We found T-cell leukaemia and lymphoma cases here could be placed into either one of the four stages of maturation proposed by the EGIL group.
Furthermore, a subset within the Pro-T and Pre-T stages could be identified by the differential expression of HLA-DR. Rearrangement in the TCRgamma gene in the various groups also presented a sequential involvement of the constant gene segments supporting an increase in maturation status according to the EGIL classification. Gene rearrangement patterns also suggested differences in HLA-DRz and HLA-DR-cases as HLA-DRz cases were found to be more immature than HLA-DR-cases in both Pro-T and Pre-T groups. Furthermore, the sequential patterns of expressions or rearrangements provide evidences to support a random targeting of normal immature cells for transformation than otherwise. These patterns may also be important to identify markers useful in prognostication.
